Health Condition 1: L20-L30- Dermatitis and eczema
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are willing and able to comply with the scheduled visits and treatment plan, laboratory testing and other study procedure and capable of providing a signed informed consent form indicating the subject has been informed of all pertinent aspects of the study.
Exclusion criteria
Exclusion criteria: 1.Patients with an evidence of clinically significant and uncontrolled systemic illness. 2.Patients with a current diagnosis of active skin disease (e.g., psoriasis, lupus erythematosus) or skin infection (bacterial, fungal or viral) especially in place of eczema at the same time. 3. Patients who had been using topical steroids within past 14 days. 4. Pregnant and lactating women. 5. Patients who have a known history or clinically relevant allergy, in particular to any component of the study treatment. 6. Patients unlikely to cooperate with the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.POEM (Patient Oriented Eczema Measure) 2. EASI (Eczema Area and Severity Index) Score 3. Pruritus NRS AssessmentTimepoint: Baseline, 2nd week ,4th week and 6th week | — |
Secondary
| Measure | Time frame |
|---|---|
| DLQI ( Dermatology Life Quality IndexTimepoint: Baseline & 6th week | — |
Countries
India
Contacts
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital